- Home
- RGLD vs ASND Comparison
RGLD vs ASND Comparison
Compare RGLD & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLD
- ASND
- Stock Information
- Founded
- RGLD 1981
- ASND 2006
- Country
- RGLD United States
- ASND Denmark
- Employees
- RGLD N/A
- ASND N/A
- Industry
- RGLD Precious Metals
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- RGLD Industrials
- ASND Health Care
- Exchange
- RGLD Nasdaq
- ASND Nasdaq
- Market Cap
- RGLD 10.6B
- ASND 10.6B
- IPO Year
- RGLD N/A
- ASND 2015
- Fundamental
- Price
- RGLD $184.86
- ASND $205.91
- Analyst Decision
- RGLD Buy
- ASND Strong Buy
- Analyst Count
- RGLD 6
- ASND 16
- Target Price
- RGLD $191.50
- ASND $240.75
- AVG Volume (30 Days)
- RGLD 744.5K
- ASND 510.4K
- Earning Date
- RGLD 11-05-2025
- ASND 08-07-2025
- Dividend Yield
- RGLD 0.97%
- ASND N/A
- EPS Growth
- RGLD 86.84
- ASND N/A
- EPS
- RGLD 6.82
- ASND N/A
- Revenue
- RGLD $791,923,000.00
- ASND $576,332,355.00
- Revenue This Year
- RGLD $18.29
- ASND $101.37
- Revenue Next Year
- RGLD $18.17
- ASND $76.17
- P/E Ratio
- RGLD $27.11
- ASND N/A
- Revenue Growth
- RGLD 30.42
- ASND 54.50
- 52 Week Low
- RGLD $130.67
- ASND $111.09
- 52 Week High
- RGLD $191.78
- ASND $207.00
- Technical
- Relative Strength Index (RSI)
- RGLD 68.53
- ASND 68.12
- Support Level
- RGLD $177.62
- ASND $195.00
- Resistance Level
- RGLD $185.38
- ASND $203.59
- Average True Range (ATR)
- RGLD 4.09
- ASND 6.41
- MACD
- RGLD 0.87
- ASND 0.27
- Stochastic Oscillator
- RGLD 95.72
- ASND 93.94
About RGLD Royal Gold Inc.
Royal Gold Inc enquires and manages precious metal royalties and streams with a focus on gold. The company purchases a percentage of the metal produced from a mineral property for an initial payment without assuming responsibility for mining operations. Similarly, precious metal streams are purchase agreements with mine operators providing the right to purchase all or a portion of one or more metals produced from a mine in exchange for an upfront deposit payment. Generally, Royal Gold does not work on the properties in which it holds royalty and streaming assets. The company owns a portfolio of producing, development, evaluation, and exploration royalties and streams, and the majority of group revenue is generated from Canada, Mexico, Chile, and the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.